Connect Biopharma Holdings Limited

NasdaqGM:CNTB 株式レポート

時価総額:US$77.9m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Connect Biopharma Holdings マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Barry Quart

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間2.8yrs
取締役会の平均在任期間3.7yrs

経営陣の近況

Recent updates

Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Strong Position To Grow Its Business

Sep 27
Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Strong Position To Grow Its Business

Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Mar 07
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Sep 19
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Mar 29
Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Dec 14
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Market Appears To Relegate Connect Biopharma To A Long-Term Hold

Oct 10

Connect Biopharma Is A Sleeper Heading Into October Data Readout

Sep 26

Connect Biopharma reports 1H results

Sep 13

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Aug 12
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Apr 29
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Connect Biopharma's Latest Dermatitis Drug Update Fails To Pump Up Shares

Jan 12

We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

Jan 01
We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

CEO(最高経営責任者

Barry Quart (67 yo)

less than a year

在職期間

Dr. Barry D. Quart, Pharm D., serves as Chief Executive Officer & Director of Connect Biopharma Holdings Limited since June 12, 2024. He had served as Chief Executive Officer of Heron Therapeutics, Inc. si...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Zheng Wei
Co-Founder & Director12.7yrsデータなし10.73%
$ 8.4m
Wubin Pan
Co-Founder & Directorno dataデータなし11.22%
$ 8.7m
Steven Chan
Chief Financial Officer2.8yrsデータなし0.014%
$ 10.6k
Barry Quart
CEO & Directorless than a yearデータなしデータなし
David Szekeres
Presidentless than a yearデータなしデータなし
Jiang Bian
General Counsel & Chief Compliance Officer3.1yrsデータなしデータなし
Lei Sun
VP of Biologics & Head of CMC4.7yrsデータなしデータなし
Raul Collazo
VP & Global Head of Medical Affairsno dataデータなしデータなし
Srikanth Pendyala
Senior Vice President of Clinical Development(Consultant)less than a yearデータなしデータなし

2.8yrs

平均在職期間

59.5yo

平均年齢

経験豊富な経営陣: CNTBの経営陣は 経験豊富 であると考えられます ( 2.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Zheng Wei
Co-Founder & Director12.7yrsデータなし10.73%
$ 8.4m
Wubin Pan
Co-Founder & Director12.3yrsデータなし11.22%
$ 8.7m
Barry Quart
CEO & Directorless than a yearデータなしデータなし
Stuart J. Swiedler
Member of Scientific Advisory Board3.7yrsデータなしデータなし
Jean I. Liu
Independent Director3.1yrsデータなし0%
$ 0
Karen Wilson
Independent Non-Executive Director3.8yrsデータなし0.018%
$ 14.1k
Kleanthis Xanthopoulos
Independent Chairman3.8yrsデータなし0%
$ 0
Brian Gordon Feagan
Member of Scientific Advisory Board3.7yrsデータなしデータなし
David T. Rubin
Member of Scientific Advisory Board3.7yrsデータなしデータなし
Emma Guttman-Yassky
Member of Scientific Advisory Board3.7yrsデータなしデータなし
Kan Chen
Independent Non-Executive Director3.8yrsデータなしデータなし
Edward M. Kerwin
Member of Scientific Advisory Board3.7yrsデータなしデータなし

3.7yrs

平均在職期間

60.5yo

平均年齢

経験豊富なボード: CNTBの 取締役会経験豊富 であると考えられます ( 3.6年の平均在任期間)。